Aroca Gustavo, Vélez-Verbel María, Cadena Andrés, Avendaño Lil Geraldine, Hernández Sandra, Sierra Angélica, Cabarcas Omar, Depine Santos Ángel
Facultad de Nefrología, Universidad Simón Bolívar, Barranquilla, Colombia; Departamento de Nefrología, Clínica de la Costa, Barranquilla, Colombia.
Facultad de Ciencias de la Salud, Programa de Medicina, Universidad Libre, Barranquilla, Colombia.
Biomedica. 2020 Oct 30;40(Supl. 2):50-67. doi: 10.7705/biomedica.5743.
At the end of 2019, in Wuhan, China, the outbreak of a new coronavirus began and quickly spread throughout the world infecting and claiming thousands of lives. To date, certain comorbidities are known to be risk factors for unsatisfactory disease outcomes, but little has been reported regarding hemodialysis patients despite being a population at high risk of infection, complications, and death. Here we describe the clinical course, clinical manifestations and complications of COVID-19 in seven patients on permanent hemodialysis. We also make recommendations for the management of patients with chronic kidney disease.
2019年底，新型冠状病毒在中国武汉爆发，并迅速蔓延至全球，感染了数千人并导致数千人死亡。迄今为止，已知某些合并症是疾病预后不佳的危险因素，但对于血液透析患者这一高感染、高并发症及高死亡风险人群，相关报道却很少。在此，我们描述了7例维持性血液透析患者感染新型冠状病毒肺炎（COVID-19）的临床病程、临床表现及并发症。我们还对慢性肾脏病患者的管理提出了建议。
